SLC5A2 and diabetes mellitus: Future research should investigate how sex-specific factors influence glycemic control and the efficacy of diabetes treatments, such as SGLT2 inhibitors and GLP-1 receptor agonists, which have demonstrated cardiorenal benefits (58).